Lifeward ltd (LFWD) - News Archive

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 Lifeward, a pioneering company at the forefront of medical technology, has announced the launch of the ReWalk 7 personal exoskeleton in the U.S. market. This...

Lifeward and MYOLYN have amplified their collaborative efforts to broaden the reach of the MyoCycle Functional Electrical Stimulation (FES) Cycling Therapy System, facilitating greater patient access to this advanced re...

Lifeward Ltd. (Nasdaq: LFWD), a key player in the healthcare sector focused on rehabilitation and recovery solutions, recently issued a year-end open letter to shareholders detailing its operational and commercial prior...

On January 13, 2025, Lifeward Ltd. (Nasdaq: LFWD), a leading medical technology company with headquarters in Marlborough, Massachusetts, and Yokneam Ilit, Israel, announced the cancellation of its Extraordinary General...

Lifeward Secures $5 Million Through Strategic Direct Offering: A Breakthrough for Rehabilitation SolutionsIn an impressive maneuver signaling its growth momentum, Lifeward Ltd. (Nasdaq: LFWD) announced the successful cl...

In a significant move set to redefine their market presence, Lifeward GmbH has announced the launch of direct sales for the AlterG product line throughout Germany. This strategic shift marks a pivotal moment not only fo...

In a move that underscores its commitment to pioneering advancements in spinal injury treatment and rehabilitation technology, Lifeward has made two significant announcements set to shape the landscape of healthcare. Th...

Introducing AlterG NEO: Revolutionizing Physical Rehabilitation and Athletic TrainingLifeward, a pioneer in innovative healthcare technology, recently unveiled its latest addition to the highly acclaimed AlterG Anti-Gra...

The finalized Medicare reimbursement pathway for personal exoskeletons has been a game-changer for eligible Medicare beneficiaries. This new development has significantly expanded access to cutting-edge technology that...

An Exoskeleton Revolution: Lifeward CEO Addressing Medicare Payment Rate and Collaboration Challenges with CMSIn a recent open letter to shareholders, the CEO of Lifeward, a leading exoskeleton manufacturer, discussed t...